Liposome surface modification by phospholipid chemical reactions

被引:34
作者
Correia de Lima, Pedro Henrique [1 ]
Butera, Anna Paola [2 ]
Cabeca, Luis Fernando [1 ,3 ]
Ribeiro-Viana, Renato Marcio [1 ,3 ]
机构
[1] Univ Tecnol Fed Parana, Programa Posgrad Ciencias & Engn Mat PPGCEM UTFPR, UTFPR Ld, BR-86036370 Londrina, Parana, Brazil
[2] Univ Estadual Londrina, Dept Quim, UEL, BR-86051980 Londrina, Parana, Brazil
[3] Univ Tecnol Fed Parana, Dept Acad Quim, UTFPR Ld, Campus Londrina,Ave Pioneiros 3131, BR-86036370 Londrina, Parana, Brazil
关键词
Liposomes; Chemical modification; Nanoparticle; Phosphatidylethanolamine; Bioconjugation; Phospholipids; PEPTIDE; CANCER; DELIVERY; NANOPARTICLES; THERAPY; LIGAND; CLICK; DOXORUBICIN; NANOCARRIER; STRATEGY;
D O I
10.1016/j.chemphyslip.2021.105084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liposomal systems are well known for playing an important role as drug carriers, presenting several therapeutic applications in different sectors, such as in drug delivery, diagnosis, and in many other academic areas. A novel class of this nanoparticle is the actively target liposome, which is constructed with the surface modified with appropriated molecules (or ligands) to actively bind a target molecule of certain cells, system, or tissue. There are many ways to functionalize these nanostructures, from non-covalent adsorption to covalent bond formation. In this review, we focus on the strategies of modifying liposomes by glycerophospholipid covalent chemical reaction. The approach used in this text summarizes the main reactions and strategies used in phospholipid modification that can be carried out by chemists and researchers from other areas. The knowledge of these methodologies is of great importance for planning new studies using this material and also for manipulating its properties.
引用
收藏
页数:16
相关论文
共 68 条
[1]   Liposome: composition, characterisation, preparation, and recent innovation in clinical applications [J].
Ahmed, Kamel S. ;
Hussein, Saied A. ;
Ali, Abdelmoneim H. ;
Korma, Sameh A. ;
Qiu Lipeng ;
Chen Jinghua .
JOURNAL OF DRUG TARGETING, 2019, 27 (07) :742-761
[2]  
Akhter A., 2018, Curr. Nanosci., V14, P1
[3]   Cholesterol-Based Compounds: Recent Advances in Synthesis and Applications [J].
Albuquerque, Helio M. T. ;
Santos, Clementina M. M. ;
Silva, Artur M. S. .
MOLECULES, 2019, 24 (01)
[4]   Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells [J].
Alshaer, Walhan ;
Hillaireau, Herve ;
Vergnaud, Juliette ;
Ismail, Said ;
Fattal, Elias .
BIOCONJUGATE CHEMISTRY, 2015, 26 (07) :1307-1313
[5]   Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas [J].
Amin, Mohamadreza ;
Badiee, Ali ;
Jaafari, Mahmoud Reza .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 458 (02) :324-333
[6]   An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells [J].
Ara, Mst Naznin ;
Matsuda, Takashi ;
Hyodo, Mamoru ;
Sakurai, Yu ;
Hatakeyama, Hiroto ;
Ohga, Noritaka ;
Hida, Kyoko ;
Harashima, Hideyoshi .
BIOMATERIALS, 2014, 35 (25) :7110-7120
[7]   Biofunctionalizing nanofibers with carbohydrate blood group antigens [J].
Barr, Katie ;
Kannan, Bhuvaneswari ;
Korchagina, Elena ;
Popova, Inna ;
Ryzhov, Ivan ;
Henry, Stephen ;
Bovin, Nicolai .
BIOPOLYMERS, 2016, 105 (11) :787-794
[8]   The Staudinger Ligation [J].
Bednarek, Christin ;
Wehl, Ilona ;
Jung, Nicole ;
Schepers, Ute ;
Braese, Stefan .
CHEMICAL REVIEWS, 2020, 120 (10) :4301-4354
[9]   Liposome-protein corona in a physiological environment: Challenges and opportunities for targeted delivery of nanomedicines [J].
Caracciolo, Giulio .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (03) :543-557
[10]   Assembly into β-Sheet Structures upon Peptide-Liposome Conjugation through Copper(I)-Catalyzed [3+2] Azide-Alkyne Cycloaddition [J].
Cavalli, Silvia ;
Overhand, Mark ;
Kros, Alexander .
CHEMPLUSCHEM, 2014, 79 (04) :564-568